Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CEPTNASDAQ:IPXXNASDAQ:PUCKNASDAQ:VACH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCEPTCantor Equity Partners II$10.90-0.9%$11.27$10.71▼$11.87$336.31MN/A145,073 shs60,764 shsIPXXInflection Point Acquisition Corp. II$9.93-5.6%$10.77$9.24▼$15.25$310.31M0.1794,223 shs1.94 million shsPUCKGoal Acquisitions$12.83$12.55$10.65▼$13.45$85.58MN/A960 shsN/AVACHVoyager Acquisition$10.39-0.2%$10.34$9.95▼$11.20$329.22MN/A122,547 shs3,693 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCEPTCantor Equity Partners II0.00%+0.82%-2.14%+1,099,999,900.00%+1,099,999,900.00%IPXXInflection Point Acquisition Corp. II0.00%-11.22%-4.06%+31.52%-6.41%PUCKGoal Acquisitions0.00%0.00%+4.69%-1.35%+18.75%VACHVoyager Acquisition0.00%+0.53%+1.02%+2.25%+1,043,499,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCEPTCantor Equity Partners IIN/AN/AN/AN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/APUCKGoal AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/AVACHVoyager AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCEPTCantor Equity Partners II 0.00N/AN/AN/AIPXXInflection Point Acquisition Corp. II 4.00Strong BuyN/AN/APUCKGoal Acquisitions 0.00N/AN/AN/AVACHVoyager Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCEPTCantor Equity Partners IIN/AN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/APUCKGoal AcquisitionsN/AN/AN/AN/A($1.60) per shareN/AVACHVoyager AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCEPTCantor Equity Partners IIN/AN/A0.00∞N/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/A0.00∞N/AN/AN/AN/AN/APUCKGoal Acquisitions-$1.14MN/A0.00∞N/AN/AN/A-66.50%7/7/2025 (Estimated)VACHVoyager AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCEPTCantor Equity Partners IIN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/APUCKGoal AcquisitionsN/AN/AN/AN/AN/AVACHVoyager AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCEPTCantor Equity Partners IIN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/APUCKGoal AcquisitionsN/A0.110.11VACHVoyager AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCEPTCantor Equity Partners IIN/AIPXXInflection Point Acquisition Corp. IIN/APUCKGoal Acquisitions60.22%VACHVoyager AcquisitionN/AInsider OwnershipCompanyInsider OwnershipCEPTCantor Equity Partners IIN/AIPXXInflection Point Acquisition Corp. II20.00%PUCKGoal Acquisitions14.60%VACHVoyager AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCEPTCantor Equity Partners II230.58 millionN/AN/AIPXXInflection Point Acquisition Corp. IIN/A31.25 million25.00 millionNot OptionablePUCKGoal AcquisitionsN/A6.67 million5.79 millionNot OptionableVACHVoyager AcquisitionN/A31.62 millionN/AN/APUCK, CEPT, IPXX, and VACH HeadlinesRecent News About These CompaniesVoyager Acquisition (NASDAQ:VACH) Trading Down 0.1% - Here's WhyJune 28, 2025 | marketbeat.comVoyager Acquisition Corp. Cl A (VACH) Stock Price Today - WSJJune 27, 2025 | wsj.comSpace Firm Voyager Technologies Surges 139% After Upsized IPOJune 11, 2025 | msn.comVoyager launches IPO with $1.6 billion valuation targetJune 3, 2025 | spacenews.comSVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | manilatimes.netMVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deVERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVeraxa Biotech to merge with SPAC Voyager in $1.64 billion dealApril 23, 2025 | msn.comFrom Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQApril 23, 2025 | markets.businessinsider.comXlife Sciences’ VERAXA Biotech to Merge with Voyager Acquisition Corp.April 23, 2025 | tipranks.comVERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination to Advance Next-Generation Cancer TherapiesApril 23, 2025 | quiverquant.comQVoyager Technologies Added To Air Force $46 Billion Agile Acquisition ContractApril 17, 2025 | aviationtoday.comAVoyager Onboards USAF Enterprise-wide Agile Acquisition ContractApril 7, 2025 | tmcnet.comWedbush assumes coverage of Voyager with outperform ratingNovember 29, 2024 | seekingalpha.comVoyager Acquisition Corp (VACH)October 17, 2024 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseQualcomm’s Hold Rating Misses Strong Growth StoryBy Jeffrey Neal Johnson | July 4, 2025View Qualcomm’s Hold Rating Misses Strong Growth StoryPUCK, CEPT, IPXX, and VACH Company DescriptionsCantor Equity Partners II NASDAQ:CEPT$10.90 -0.10 (-0.91%) As of 04:00 PM EasternCantor Equity Partners II, Inc. is a blank check company. The company was founded on November 11, 2020 and is headquartered in New York, NYInflection Point Acquisition Corp. II NASDAQ:IPXX$9.93 -0.59 (-5.61%) As of 07/3/2025Inflection Point Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in New York, New York.Goal Acquisitions NASDAQ:PUCK$12.82 0.00 (0.00%) As of 07/3/2025Goal Acquisitions Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Goal Acquisitions Corp. was incorporated in 2020 and is based in Bee Cave, Texas.Voyager Acquisition NASDAQ:VACH$10.39 -0.02 (-0.18%) As of 03:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Voyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
